Role of bombesin-related peptides in the mediation or integration of the stress response

Cellular and Molecular Life Sciences

Volumn 59, Issue 2, 2002, Pages 272-287

  Merali, Z ^a   Kent, P ^a   Anisman, H ^b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b CARLETON UNIVERSITY   (Canada)

Author keywords

Gastrin releasing peptide; Neuroendocrine; Neuromedin B; Pathology; Stress

Indexed keywords

ARGIPRESSIN; CORTICOTROPIN RELEASING FACTOR; NEUROMEDIN B;

NEUROCHEMISTRY; PROTEIN BINDING; PROTEIN INTERACTION; REVIEW; STRESS;

ANIMALS; BOMBESIN; BRAIN; GASTRIN-RELEASING PEPTIDE; HORMONES; HUMANS; MODELS, BIOLOGICAL; NEUROKININ B; RATS; RECEPTORS, BOMBESIN; STRESS; TRANSCRIPTION, GENETIC;

EID: 0036178452     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-002-8422-x     Document Type: Review

References (110)

1. Understanding stress: Characteristics and caveats
2. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory and preparative actions
3. Stress-induced behaviors require the corticotropin-releasing hormone (CRH) receptor, but not CRH
4. Mechanisms of stress: A dynamic overview of hormonal and behavioral homeostasis
5. Sympathoadrenal system in stress
6. Mediation of the stress response by the hypothalamic-pituitary-adrenal axis
7. Noradrenergic mechanisms in stress and anxiety: I. Preclinical studies
8. Neurocircuitry of stress: Central control of the hypothalamo-pituitary-adrenocortical axis
9. Neuroendocrinology and pathophysiology of the stress system
10. The predator odor, TMT, displays a unique, stress-like pattern of dopaminergic and endocrinological activation in the rat
11. Isolation and structure of bombesin and alytesin, two analogous active peptides from the skin of the european amphibian bombina and alytes
12. Characterization of a gastrin releasing peptide from porcine non-antral gastric tissue
13. Neuromedin B: A novel bombesin-like peptide identified in porcine spinal cord
14. Discovery of a high affinity radioligand for the human orphan receptor, bombesin receptor subtype 3, which demonstrates that it has a unique pharmacology compared with other mammalian bombesin receptors
15. Pattern and time course of immediate early gene expression in rat brain following acute stress
16. Differential expression of fos family and jun family mRNAs in the rat hypothalamo-pituitary-adrenal axis after immobilization stress
17. Induction of multiple immediate early genes in rat hypothalamic paraventricular nucleus after stress
18. Stress-induced changes of gene expression in the paraventricular nucleus are enhanced in spontaneously hypertensive rats
19. Different expression of immediate-early genes in the rat paraventricular nucleus induced by stress: Relation to corticotropin-releasing factor gene transcription
20. Neuronal location of the bombesin-like immunoreactivity in the central nervous system of the rat
21. Distribution and molecular forms of immunoreactive bombesin in the ovine median eminence
22. Gastrin releasing peptide (GRP) is present in a GRP (1-27) form in anterior pituitary cells of the guinea pig
23. Bombesin-like immunoreactivity in bovine adrenal medulla
24. Neuromedin B and gastrin-releasing peptide mRNAs are differentially distributed in the rat nervous system
25. Two distinct receptor subtypes for mammalian bombesin-like peptides
26. Expression of the genes encoding bombesin-related peptides and their receptors in anterior pituitary tissue
27. Localization of receptors for bombesin-like peptides in the rat brain
28. Bombesin: Receptor distribution in brain and effects on nociception and locomotor activity
29. Autoradiographic localization of (125I-tyr4)bombesin-binding sites in rat brain
30. Autoradiographic visualization of rat brain binding sites for bombesin-like peptides
31. Distinct distributions of two bombesin receptor subtypes in the rat central nervous system
32. Biochemical localization and characterization of bombesin-like peptides in discrete regions of rat brain
33. Biochemical and histochemical characterization of ranatensin immunoreactive peptides in rat brain: Lack of coexistence with bombesin/GRP
34. Bombesin-like peptides depolarize rat hippocampal interneurones through interaction with subtype 2 bombesin receptors
35. Are bombesin-like peptides involved in the mediation of stress response?
36. Differential effects of psychogenic and neurogenic stressors on central corticotropin-releasing hormone and bombesin-like peptides in fast and slow seizing rat
37. A comparison of two immediate-early genes, c-fos and NGFI-B, as markers for functional activation in stress-related neuroendocrine circuitry
38. Neuronal organization of stress response: Pain-induced c-fos expression in brainstem catecholaminergic cell groups
39. Aversive and appetitive events evoke the release of corticotropin-releasing hormone and bombesin-like peptides at the central nucleus of the amygdala
40. Central bombesin activates the hypothalamic-pituitary-adrenal axis: Effects on regional levels and release of corticotropin-releasing hormone and arginine vasopressin
41. Bombesin regulation of adrenocorticotropin release from ovine anterior pituitary cells
42. Hypothalamus, anterior pituitary and adrenal gland involvement in the activation of adrenocorticotropin and corticosterone secretion by gastrin-releasing peptide
43. Role of corticotropin-releasing hormone in gastrin-releasing peptide-mediated regulation of corticotropin and corticosterone secretion in male rats
44. Gastrin-releasing peptide stimulation of corticotropin secretion in male rats
45. Bombesin microinfusion into the rat hypothalamic paraventricular nucleus increases blood glucose, free fatty acids and corticosterone
46. Investigations on the acute effects of neuropeptides on the pituitary-adrenocortical function in normal and cold- stressed rats. I. Bombesin and neuromedin B
47. Role of neuromedins in the regulation of adrenocortical function
48. Influence of bombesin, CCK, secretin and CRF on corticosterone concentration in the rat
49. Gastrin releasing peptide, but not pentagastrin, stimulates ACTH and cortisol secretion in conscious dogs
50. Influence of CCK and bombesin on ACTH and cortisol secretion in the conscious dog
51. Corticotropin-releasing activity of gastrin-releasing peptide in normal men
52. Central nervous system action of bombesin: Mechanism to induce hyperglycemia
53. Bombesin: Central nervous system actions to affect the autonomic nervous system
54. Central nervous system site of action of bombesin to elevate plasma concentrations of catecholamines
55. Brain prostaglandins mediate the bombesin-induced increase in plasma levels of catecholamines
56. Effects of central neuromedin B and related peptides on blood glucose
57. Glucoregulatory effects of intrahypothalamic injections of bombesin and other peptides
58. Chemical sympathectomy with 6-hydroxydopamine potentiates intracere-broventricularly applied bombesin-induced increase in plasma adrenaline
59. Centrally applied bombesin increases nerve activity of both sympathetic and adrenal branch of the splanchnic nerves
60. Central nervous system cardiovascular effects of bombesin in conscious rats
61. Behavioral effects of bombesin administration in rats
62. Intravenous infusion of bombesin reduces food intake in humans
63. Specific neuroanatomical and neurochemical correlates of locomotor and grooming effects of bombesin
64. Openfield behavior of rats following intracerebroventricular administration of neuromedin B, neuromedin C and related amphibian peptides
65. Physiological and behavioral responses to corticotropin-releasing factor administration: Is CRF a mediator of anxiety or stress responses
66. CRF antagonist partially reverses CRF- and stress-induced effects on feeding
67. Centrally and peripherally administered bombesin decreases food intake in turkeys
68. Effects of pancreatic polypeptide, caerulein, and bombesin on satiety in obese mice
69. Bombesin suppresses feeding in rats
70. Anorectic action of bombesin requires receptor for corticotropin-releasing factor but not for oxytocin
71. Peripherally and centrally administered bombesin induce Fos-like immunoreactivity in different brain regions in rats
72. Regulation of ingestion by CRF and bombesin-like peptides: Distinct meal-related peptide level changes
73. Push-pull perfusion reveals meal-dependent changes in the release of bombesin-like peptides in the rat paraventricular nucleus
74. Caudal hindbrain participation in the suppression of feeding by central and peripheral bombesin
75. Intraventricular bombesin (BBS) reduces food intake of normal but not area-postrema-lesioned rats
76. Behavior of the Roman/Verh high- and low-avoidance rat lines in anxiety tests: Relationship with defecation and self-grooming
77. Effect of stress on behaviour in rats
78. Ethology and neurobiology of grooming behavior
79. Studies on bombesin-induced grooming in rats
80. Behavioral effects of bombesin
81. 2 receptor agonists and antagonists on bombesin-induced behaviors
82. Role of the cholinergic system(s) in the expression of the behavioral effects of bombesin
83. Comparison of bombesin-, ACTH- and beta-endorphin-induced grooming. Antagonism by haloperidol, naloxone and neurotensin
84. Bombesin-induced behavioral changes: Antagonism by neuroleptics
85. Bombesin-induced locomotor hyperactivity: Evaluation of the involvement of the mesolimbic dopamine system
86. Postnatal handling reduces novelty-induced fear and increases (3H)flunitrazepam binding in rat brain
87. Novelty-induced delay in snack approach: A robust and rapid naturalistic model for anxiety assessment
88. PD 176252 - The first high affinity non-peptide gastrin-releasing peptide (BB2) receptor antagonist
89. Comparative pharmacology of PD 108368, a non-peptide neuromedin B antagonist
90. Opioid and nonopioid mechanisms of stress analgesia
91. Opioid and non-opioid stress analgesia: Assessment of tolerance and cross-tolerance with morphine
92. Bombesin-induced HPA and sympathetic activation requires CRH receptors
93. Potentiation by bombesin of corticotropin-releasing factor- stimulated ACTH release is dependent on the presence of glucocorticoids
94. Central bombesin administration elicits site-specific alterations in the levels of corticotropin-releasing hormone (CRH) and arginine vasopressin (AVP) immunoreactivity
95. A neuroanatomy of stress
96. Anatomical specificity of noradrenergic inputs to the paraventricular and supraoptic nuclei of the rat hypothalamus
97. Organization of adrenergic inputs to the paraventricular and supraoptic nuclei of the hypothalamus in the rat
98. Distribution of bombesin-like immunoreactivity in the nucleus of the solitary tract and dorsal motor nucleus of the rat and human: Colocalization with tyrosine hydroxylase
99. Bombesin immunoreactive neurons in the hypothalamic paraventricular nucleus innervate the dorsal vagal complex in the rat
100. Co-localzation of corticotropin-releasing factor and vasopressin in median eminence neurosecretory vesicles
101. Multiple cholecystokinin (CCK) receptors and CCK-monoamine interactions are instrumental in the control of feeding
102. Abnormalities in plasma and cerebrospinal-fluid arginine vasopressin in patients with anorexia nervosa
103. Psychoneuroendocrinology of depression
104. Elevated CSF CRF in suicide victims
105. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients
106. CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia
107. Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients
108. Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims
109. Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression